{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T22:36:48Z","timestamp":1761863808304,"version":"build-2065373602"},"reference-count":17,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the National Medical Association"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.jnma.2024.01.007","type":"journal-article","created":{"date-parts":[[2024,1,20]],"date-time":"2024-01-20T23:40:25Z","timestamp":1705794025000},"page":"174-179","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"P1","title":["Emerging data in COVID-19 create urgent challengers for health providers: Updates on COVID-19 vaccine and Paxlovid"],"prefix":"10.1016","volume":"116","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0703-8688","authenticated-orcid":false,"given":"Maria Carmenza","family":"Mejia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Mitchell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meghana","family":"Dumpa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6762-2291","authenticated-orcid":false,"given":"Dennis G.","family":"Maki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4087-9668","authenticated-orcid":false,"given":"Mark","family":"DiCorcia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert S.","family":"Levine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1214-1663","authenticated-orcid":false,"given":"Charles H.","family":"Hennekens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.jnma.2024.01.007_bib0001","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/j.amjmed.2020.04.009","article-title":"Racial Inequalities in mortality from coronavirus: the tip of the iceberg","volume":"133","author":"Levine","year":"2020","journal-title":"Am J Med"},{"issue":"12","key":"10.1016\/j.jnma.2024.01.007_bib0002","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph17124322","article-title":"Black-white risk differentials in COVID-19 (SARS-COV2) transmission, mortality and case fatality in the United States: translational epidemiologic perspective and challenges","volume":"17","author":"Holmes","year":"2020","journal-title":"Int J Environ Res Public Health"},{"issue":"26","key":"10.1016\/j.jnma.2024.01.007_bib0003","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.1056\/NEJMsa2011686","article-title":"Hospitalization and mortality among black patients and white patients with Covid-19","volume":"382","author":"Price-Haywood","year":"2020","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.jnma.2024.01.007_bib0004","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/j.amjmed.2022.02.041","article-title":"Cautious optimism and considerations for health providers and patients: oral antiviral for early treatment of high-risk patients and vaccines for prevention of COVID-19","volume":"135","author":"Caceres","year":"2022","journal-title":"Am J Med"},{"key":"10.1016\/j.jnma.2024.01.007_bib0005","unstructured":"FDA. FDA Takes action on updated mRNA COVID-19 vaccines to better protect against currently circulating variants. FDA News Release. September 11, 2023. Accessed 11\/28\/23. https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-takes-action-updated-mrna-covid-19-vaccines-better-protect-against-currently-circulating."},{"year":"2023","series-title":"COVID Data Tracker","key":"10.1016\/j.jnma.2024.01.007_bib0006"},{"key":"10.1016\/j.jnma.2024.01.007_bib0007","unstructured":"Centers for Disease Control and Prevention. Risk for COVID-19 Infection, hospitalization, and death by race\/ethnicity. Updates May 25, 2023. Accessed August 3, 2023. https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/covid-data\/investigations-discovery\/hospitalization-death-by-race-ethnicity.html."},{"key":"10.1016\/j.jnma.2024.01.007_bib0008","unstructured":"Moderna. Moderna clinical trial data confirm its updated Covid-19 vaccine generates robust immune response in humans against widely circulating variants. August 17, 2023. https:\/\/investors.modernatx.com\/news\/news-details\/2023\/Moderna-Clinical-Trial-Data-Confirm-Its-Updated-COVID-19-Vaccine-Generates-Robust-Immune-Response-in-Humans-Against-Widely-Circulating-Variants\/default.aspx."},{"key":"10.1016\/j.jnma.2024.01.007_bib0009","unstructured":"COVID-19 cases, deaths, and vaccinations by race\/ethnicity as of winter 2022. 2023. https:\/\/www.kff.org\/coronavirus-covid-19\/issue-brief\/covid-19-cases-deaths-and-vaccinations-by-race-ethnicity-as-of-winter-2022\/. Accessed 08\/28\/2023."},{"key":"10.1016\/j.jnma.2024.01.007_bib0010","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1353\/dem.2004.0030","article-title":"The increasing racial disparity in infant mortality: respiratory distress syndrome and other causes","volume":"41","author":"Frisbie","year":"2004","journal-title":"Demography"},{"key":"10.1016\/j.jnma.2024.01.007_bib0011","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2020.100350","article-title":"A descriptive study of racial inequalities in mortality from hepatocellular cancer before and after licensure of lifesaving drugs for hepatitis C virus in the United States","volume":"22","author":"Levine","year":"2020","journal-title":"EClinicalMedicine"},{"issue":"7","key":"10.1016\/j.jnma.2024.01.007_bib0012","doi-asserted-by":"crossref","first-page":"553","DOI":"10.2307\/4591208","article-title":"The changing pattern of poliomyelitis observed in two urban epidemics","volume":"76","author":"Chin","year":"1961","journal-title":"Public Health Rep"},{"key":"10.1016\/j.jnma.2024.01.007_bib0013","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.15585\/mmwr.mm7143a2","article-title":"Racial and ethnic disparities in outpatient treatment of COVID-19 United States, January\u2013July 2022","volume":"71","author":"Boehmer","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"11","key":"10.1016\/j.jnma.2024.01.007_bib0014","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1001\/jama.2011.322","article-title":"Statistical association and causation: contributions of different types of evidence","volume":"305","author":"Hennekens","year":"2011","journal-title":"Jama"},{"issue":"1","key":"10.1016\/j.jnma.2024.01.007_bib0015","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1093\/qje\/qjx029","article-title":"Tuskegee and the health of Blacks men","author":"Alsan","year":"2018","journal-title":"Q J Econ"},{"key":"10.1016\/j.jnma.2024.01.007_bib0016","doi-asserted-by":"crossref","first-page":"437","DOI":"10.15585\/mmwr.mm7216a5","article-title":"The Association of Reported Experiences of Racial and Ethnic Discrimination in Health Care with COVID-19 Vaccination Status and Intent United States, April 22, 2021\u2013November 26, 2022","volume":"72","author":"Elam-Evans","year":"2023","journal-title":"MMWR Morb Mortal Wkly Rep"},{"year":"1985","series-title":"Report of the Secretary's Task Force on Black and Minority Health","author":"Heckler","key":"10.1016\/j.jnma.2024.01.007_bib0017"}],"container-title":["Journal of the National Medical Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002796842400004X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002796842400004X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T06:20:42Z","timestamp":1758435642000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002796842400004X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":17,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["S002796842400004X"],"URL":"https:\/\/doi.org\/10.1016\/j.jnma.2024.01.007","relation":{},"ISSN":["0027-9684"],"issn-type":[{"type":"print","value":"0027-9684"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Emerging data in COVID-19 create urgent challengers for health providers: Updates on COVID-19 vaccine and Paxlovid","name":"articletitle","label":"Article Title"},{"value":"Journal of the National Medical Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jnma.2024.01.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 National Medical Association. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}